That red mark after your Mounjaro injection — what's normal and what isn't

You've just done your injection and noticed a red patch, here's what's likely happening

You press the KwikPen against your skin, wait for the click, hold it in place, and then pull it away. A minute later there's a pink or red circle, maybe a centimetre or two across, sometimes tender to touch. This is the most familiar injection-site reaction people report with Mounjaro, and if you want to understand exactly what causes it and what to expect, our guide to the red mark around a Mounjaro injection site covers the topic in full. The skin is responding to a small physical insult (a needle has passed through it) and to the medicine itself entering the subcutaneous tissue. Both things together can trigger a brief inflammatory response that looks exactly like that small red mark.

For most people the redness fades within a few hours. Some find a faint pink patch lingers until the next morning. That's still within the range that clinicians consider normal. If you noticed redness after your first pen, it may have been more noticeable than subsequent ones, the body often settles into the routine. Reactions also tend to flare again briefly after each dose increase, then calm down as before.

One practical thing that helps: let the pen come to room temperature before injecting rather than using it straight from the fridge. Cold medicine entering the tissue is more likely to produce a stinging, red reaction. The full injection technique guide covers this and other steps that can make each dose more comfortable.

When the redness is something to look at more carefully

Most injection-site redness is benign and self-limiting. But there are patterns that deserve a closer look, and your prescriber will want to know about them.

A red mark that spreads significantly beyond the injection point over the hours following your dose (rather than staying roughly circular and small) is worth monitoring. If it's still growing the next day, contact your prescriber or GP rather than waiting for your next check-in. Similarly, a hard lump or nodule under the skin that doesn't soften within a week can indicate lipohypertrophy, a localised thickening of fatty tissue that develops when the same spot is used repeatedly. The medicine absorbs less consistently from a lipohypertrophied site, which can affect how well your treatment works.

Signs of infection (skin that is hot to the touch, increasingly swollen, discharging fluid, or accompanied by a fever) are different from ordinary injection reactions and need prompt attention. The detailed guide to red injection sites goes through the distinguishing features in more practical terms. If you're ever unsure whether what you're seeing is normal, the NHS medicines page for tirzepatide on NHS.uk lists the expected side effects, which is a useful reference point.

A more widespread skin reaction (itching that extends well beyond the injection point, hives, or any difficulty breathing) is rare but serious. Treat it as an allergic reaction and seek medical help straight away rather than waiting to see if it settles.

Practical steps that reduce injection-site reactions

There's quite a lot within your control. Rotating sites is the single most effective measure: use the abdomen one week, the thigh the next, the upper arm after that, and never inject into the same small spot twice in a row. Within each zone, move at least a couple of centimetres from the previous site. Some people find this easier once they've written a simple pattern down, a question our prescribers hear regularly is whether strict rotation really matters, and the short answer is yes.

Letting the skin dry fully after cleaning it with an alcohol swab before injecting also reduces irritation; damp skin and alcohol left on the surface can both contribute to stinging. Inject slowly and steadily, keep the pen pressed flat against the skin for the full duration the leaflet specifies, and don't rub the area afterwards, rubbing spreads the medicine unevenly and can increase local inflammation.

If you're finding that reactions are consistently pronounced week after week, that's worth raising at your next review. There may be a technique adjustment that helps, or it may reflect something worth noting in your clinical record. You can always reach the aftercare team via our contact page between reviews.

When to get medical help and how to report reactions

The NHS and the MHRA both encourage people to report side effects that feel significant, and injection-site reactions are included. If you experience something that concerns you (particularly anything that looks like an infection, a persistent lump, or a widespread skin response) report it through the MHRA's Yellow Card scheme as well as speaking to your prescriber. Yellow Card reports from real patients are part of how the regulator monitors medicines after they're licensed, and every report contributes to the safety picture.

For anyone curious about what itching specifically at the site might mean, the page on red, itchy spots after a Mounjaro injection covers that variation in more detail. A broader skin reaction with a rash pattern is explored separately in the guide to rashes after Mounjaro.

Mounjaro is a prescription medicine, and the prescriber who reviews your treatment is best placed to assess anything out of the ordinary. If you haven't yet started treatment and are weighing up your options, you can read more about how Mounjaro works or explore the treatment options available through a free consultation with our clinical team.